These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9225710)

  • 81. Effect of vitamin D supplementation as adjunctive therapy to methylphenidate on ADHD symptoms: A randomized, double blind, placebo-controlled trial.
    Mohammadpour N; Jazayeri S; Tehrani-Doost M; Djalali M; Hosseini M; Effatpanah M; Davari-Ashtiani R; Karami E
    Nutr Neurosci; 2018 Apr; 21(3):202-209. PubMed ID: 27924679
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder.
    Bilici M; Yildirim F; Kandil S; Bekaroğlu M; Yildirmiş S; Değer O; Ulgen M; Yildiran A; Aksu H
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):181-90. PubMed ID: 14687872
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism.
    Fankhauser MP; Karumanchi VC; German ML; Yates A; Karumanchi SD
    J Clin Psychiatry; 1992 Mar; 53(3):77-82. PubMed ID: 1548248
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Double-blind, placebo-controlled trial of risperidone plus amantadine in children with autism: a 10-week randomized study.
    Mohammadi MR; Yadegari N; Hassanzadeh E; Farokhnia M; Yekehtaz H; Mirshafiee O; Akhondzadeh S
    Clin Neuropharmacol; 2013; 36(6):179-84. PubMed ID: 24201232
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The use of buspirone in primary care.
    Khouzam HR; Emes R
    J Psychosoc Nurs Ment Health Serv; 2002 Jul; 40(7):34-41. PubMed ID: 12136514
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Buspirone in Autism Spectrum Disorder: A Systematic Review.
    Gupta N; Gupta M; Gandhi R
    Cureus; 2023 May; 15(5):e39304. PubMed ID: 37378184
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Anxiety in youth with autism spectrum disorders: implications for treatment.
    Johnco C; Storch EA
    Expert Rev Neurother; 2015; 15(11):1343-52. PubMed ID: 26548429
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders.
    Aman MG; Farmer CA; Hollway J; Arnold LE
    Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):713-38, vii. PubMed ID: 18775366
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Molecular dynamics of 5-HT1A and 5-HT2A serotonin receptors with methylated buspirone analogues.
    Bronowska A; Chilmonczyk Z; Leś A; Edvardsen O; Ostensen R; Sylte I
    J Comput Aided Mol Des; 2001 Nov; 15(11):1005-23. PubMed ID: 11989622
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders.
    Aman MG; Langworthy KS
    J Autism Dev Disord; 2000 Oct; 30(5):451-9. PubMed ID: 11098883
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The treatment of autism with low-dose phenytoin: a case report.
    Bird PD
    J Med Case Rep; 2015 Jan; 9():8. PubMed ID: 25592685
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Treatment with buspirone in a patient with autism.
    McCormick LH
    Arch Fam Med; 1997; 6(4):368-70. PubMed ID: 9225710
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Buspirone for Comorbid Anxiety in Autism.
    Gupta M; Gupta N; Moll J; Ramar D
    Prim Care Companion CNS Disord; 2023 Mar; 25(2):. PubMed ID: 36946573
    [No Abstract]   [Full Text] [Related]  

  • 94. A randomized double-blind placebo-controlled clinical trial of adjuvant buspirone for irritability in autism.
    Ghanizadeh A; Ayoobzadehshirazi A
    Pediatr Neurol; 2015 Jan; 52(1):77-81. PubMed ID: 25451017
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder.
    Handen BL; Johnson CR; Lubetsky M
    J Autism Dev Disord; 2000 Jun; 30(3):245-55. PubMed ID: 11055460
    [TBL] [Abstract][Full Text] [Related]  

  • 96. An 8-week, randomized controlled trial of atomoxetine, atomoxetine plus buspirone, or placebo in adults with ADHD.
    Sutherland SM; Adler LA; Chen C; Smith MD; Feltner DE
    J Clin Psychiatry; 2012 Apr; 73(4):445-50. PubMed ID: 22313788
    [TBL] [Abstract][Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.